Searched for
GLS PHARMA
Obesity drugs shed niche tag, set to gain more weight in India pharmaIndia's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The ...- Aurobindo to acquire 49 pc stake in GLS Pharma for Rs 22.5 crAurobindo Pharma Ltd will acquire the remaining 49% stake in GLS Pharma Ltd for Rs 22.5 crore, making it a wholly-owned subsidiary. The acq...
- Aurobindo to acquire 49% stake in GLS Pharma for Rs 22.5 croreAurobindo Pharma Ltd on Wednesday said it will acquire the balance 49 per cent stake in GLS Pharma Ltd for Rs 22.5 crore to make the latter...
- Glenmark closes 3% lower post API arm sale dealAccording to analysts, the sale of Glenmark Life could impact the profitability of Glenmark Pharma in FY25 but lower interest payments coul...
- Sensex extends losses to 4th session dragged by IT stocks, falls 221 points; Nifty below 19,700From the Sensex pack, Wipro, HDFC Bank, Power Grid, Sun Pharma, and UltraTech Cement closed in the red, while IndusInd Bank, Maruti, SBI, M...
- Nirma to acquire 75% of Glenmark’s API arm for Rs 5,615 crGlenmark Pharma’s stake in the leading active pharmaceutical ingredient (API) platform will drop to 7.84% from 82.84%. The transaction valu...
- ChrysCapital still in race to buy controlling stake in Glenmark Life SciencesPrivate equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma's stake in Glenmark Life Sciences (GLS) with rival bi...
- The little girl twirls on: Nirma's journey from washing powder to cement to pharmaIndia's Nirma, known for its washing detergent, is seeking to expand into the pharma sector by becoming the leading contender to buy Glenma...
- Nirma closes in on Glenmark's API arm, emerges sole contender as bid deadline endsNirma Group is likely to acquire an 82.84% stake in Glenmark Life Sciences in a deal worth INR 6,664 to INR 7,000 crore. The company has em...
- Sekhmet, Nirma in fray for Glenmark's API businessSekhmet Pharmaventures and Nirma Group are in competition to acquire Glenmark Life Sciences (GLS), the 82.85% subsidiary of Glenmark Pharma...
- Ramdev's Divya Pharmacy among 16 Indian pharma companies in Nepal blacklistThese entities have failed to comply with the World Health Organisation's (WHO) drug manufacturing standards, the Department of Drug Admini...
- Stocks in the news: ICICI Bank, Cipla, Adani Wilmar, Delhivery and Canara BankThe global rating agency Moody's Investors Service has upgraded the baseline credit assessments of ICICI Bank and Axis Bank, reflecting imp...
- As input costs soar, small drug units reach out to Centre for helpThe prices of active pharmaceutical ingredients (APIs), excipients, glass vials and packaging material, among other inputs, have escalated ...
- Glenmark Life IPO attractively pricedWith a portfolio of 120 molecules, GLS is a leading developer of select high-value, non-commoditised APIs in chronic therapies. It earns on...
- Glenmark Life’s Rs 1,514 crore IPO to open on July 27Glenmark’s share sale will be the 27th IPO of the year and fifth offering in July after GR Infraprojects, Clean Science and Technology, Zom...
- Glenmark Life’s Rs 1,600-cr issue may open next weekThe initial public offering (IPO) comprises a fresh issue of Rs 1,160 crore and sale of 7.3 million shares by listed promoter Glenmark Phar...
- SGX Nifty down 110 points; here's what changed for market while you were sleepingNifty futures on the Singapore Exchange traded 113.50 points, or 1 per cent lower at 11,227, in signs that Dalal Street was headed for a ga...
- Stocks in the news: Igarashi Motors, Glenmark Pharma, Alkem Labs, Lupin and Future RetailFidelity Investment Trust offloaded over 1.91 crore shares of LIC Housing worth nearly Rs 821 crore.
- Glenmark in talks to sell up to 30% in API biz to PremjiInvestThe pharma group plans to sell minority stake for $150m in their new subsidiary of active pharmaceutical ingredient products. Discussions a...
Load More
